Search

An 11-year-old spayed female Miniature Schnauzer dog was presented with loss of a claw caused by a nail bed mass. Histopathological evaluation revealed that the mass comprised neoplastic squamous cells with abundant cytoplasmic melanin pigment. Immunohistochemically, the neoplastic cells were positive for cytokeratin and negative for vimentin and ionized calcium-binding adaptor molecule 1, supporting a diagnosis of pigmented squamous cell carcinoma. To our knowledge, this is the first report of subungual pigmented squamous cell carcinoma in animals. [ABSTRACT FROM AUTHOR]

The cathode of a protonic ceramic fuel cell must be able to facilitate ion and electron transfer, while simultaneously possessing a high catalytic activity for steam generation and the dissociation of gas-phase molecules. In this study, the performance of a cathode for protonic ceramic fuel cells is optimized by employing a triple-component composite cathode design, which integrates proton conductors, mixed electronic–ionic conductors, and a catalytic layer. Additionally, two other composite cathodes are fabricated for comparison. Owing to its higher electrical conductivity but lower catalytic activity, the composite cathode with protonic ceramic and (Ba 0.95 La 0.05) (Fe 0.8 Zn 0.2)O 3-δ (BLFZ) exhibits lower ohmic resistance but poor catalytic activity compared to the composite cathode with protonic ceramic and Ba(Co 0.4 Fe 0.4 Zr 0.1 Y 0.1)O 3-δ (BCFZY). The triple-component cathode is fabricated by infiltrating BCFZY into a composite cathode composed of BLFZ and protonic ceramic, and both the ohmic and non-ohmic resistances of the cathode are optimized in CH 4 and H 2 fuels. In particular, the performance of CH 4 fuel is significantly improved by adopting a triple-component cathode. These results suggest a possible contribution of the oxygen reduction reaction at the cathode to the reformation of CH 4 at the anode. • Triple-component composite cathode (BCFZY/BLFZ/BCZY) were fabricated at low temp. • Optimization in ohmic and non-ohmic ASRs by BLFZ and BCFZY in the composite cathode. • Oxygen reduction reaction at cathode facilitates the methane reformation at anode. [ABSTRACT FROM AUTHOR]

Generally, the NiO composite anode becomes porous after reduction. To infiltrate additional catalysts such as Pd into the NiO-composite anode before reducing NiO to Ni, a porous NiO composite anode for protonic ceramic fuel cells (PCFCs) was fabricated in this study. The porous NiO composite was fabricated by adding graphite as a pore former along with CuO as a sintering agent. The addition of graphite increased the porosity of the NiO composite anode but resulted in poor sinterability, which was addressed by adding CuO as a sintering agent to the NiO composite anode. The Pd catalyst was added to the NiO-composite anode before reducing NiO to Ni. The composite anode for PCFC with three components, namely Ni, protonic ceramics, and a Pd catalyst, was obtained by reducing NiO to Ni during the measurement. The addition of the Pd catalyst improved the anode performance in methane fuel and hydrogen fuel by enhancing the catalytic activity for the electrochemical reaction on the surface. [ABSTRACT FROM AUTHOR]

Tumor hypoxia is known to promote the acquisition of more aggressive phenotypes in human transitional cell carcinoma (TCC), including drug resistance. Accumulating evidence suggests that mitochondria play a central role in the chemoresistance of TCC. However, the role of mitochondria in the hypoxia-induced drug resistance in TCC remains elusive. The present study investigated the function of mitochondria in the drug resistance using a TCC cell line under hypoxic conditions. In vitro hypoxia (0.1% O 2 , 48 h) was achieved by incubating TCC cells in air chamber. Mitochondrial events involving hypoxia-induced drug resistance were assessed. Hypoxia significantly reduced the cisplatin-induced apoptosis of TCC cells. Additionally, hypoxia substantially decreased the level of mitochondrial reactive oxygen species (ROS) generated by cisplatin treatment. Analogously, elimination of mitochondrial ROS significantly rescued cells from cisplatin-induced apoptosis. Hypoxia enhanced mitochondrial hyperpolarization, which was not related to ATP production or the reversal of ATP synthase activity. The mitochondrial DNA (mtDNA) amplification efficiency data illustrated that hypoxia significantly prevented oxidative damage to the mitogenome. Moreover, transmission electron microscopy revealed that cisplatin-induced disruption of the mitochondrial ultrastructure was abated under hypoxic conditions. Notably, depletion of mtDNA by ethidium bromide abrogated hypoxia-induced resistance to cisplatin. Taken together, the present study demonstrated that TCC cells exposed to hypoxic conditions rendered mitochondria less sensitive to oxidative stress induced by cisplatin treatment, leading to enhanced drug resistance. [ABSTRACT FROM AUTHOR]

Composite anodes of nano-sized Ni and Ba(Zr 0.85 Y 0.15)O 3-δ (BZY) were fabricated by infiltrating a single precursor solution of BZY and Ni into the BZY scaffold, and decreasing the calcination temperature to 1173 K. This decrease in the fabrication temperature of the Ni-cermet anode prevents the chemical reaction between the electrolyte and nickel, thus preventing a reduction in the conductivity of the electrolyte. By optimizing the amount of Ni in the Ni-cermet and infiltrating additional catalysts such as CeO 2 and Pd, the non-ohmic ASR of the Ni-cermet anode could be optimized. This resulted in a smaller non-ohmic ASR of anode than one that was fabricated by the conventional co-sintering method. Consequently, a high power density of 790 mW/cm2 at 973 K can be obtained from electrolyte-supported cells. • BZY-Ni composite anode were successfully fabricated at low temperature of 1173 K. • Chemical reaction of Ni and electrolyte was prevented by low temperature fabrication. • No degradation of ionic conductivity of electrolyte owing to the Ni incorporation. • Additional catalysts of CeO 2 and Pd in BZY-Ni improved the performance further. [ABSTRACT FROM AUTHOR]